Variables | No. patients | Univariate | Multivariate | ||
---|---|---|---|---|---|
 |  | p-valuea | HR (95% CI) | p-valueb | HR (95% CI) |
Sex | Â | Â | Â | Â | Â |
 Female | 26 | 0.98 | 0.99 (0.39-2.51) | 0.92 | 1.05 (0.40-2.73) |
 Male | 77 |  |  |  |  |
Age | 32-87 years | 0.96 | 1.00 (0.96-1.04) | 0.97 | 1.00 (0.96-1.04) |
T stage | Â | Â | Â | Â | Â |
 T1 | 62 | 7.32 × 10-06 | 0.10 (0.03-0.27) | 7.27 × 10-06 | 0.09 (0.03-0.27) |
 T2 | 16 | 0.12 | 0.413 (0.14-1.26) | 0.12 | 0.41 (0.13-1.26) |
 T3 | 25 |  |  |  |  |
ALDH2 | Â | Â | Â | Â | Â |
 Low | 54 | 1.69 × 10-04 | 52.02 (6.63-407.94) | 2.11 × 10-04 | 81.91 (7.96-842.24) |
 High | 49 |  |  |  |  |
CCNE1 | Â | Â | Â | Â | Â |
 Low | 59 | 4.53 × 10-04 | 41.4 (5.17-331.66) | 6.38 × 10-04 | 36.27 (4.24-309.92) |
 High | 44 |  |  |  |  |
SMAD3 | Â | Â | Â | Â | Â |
 Low | 62 | 9.51 × 10-04 | 31.14 (4.05-239.33) | 1.04 × 10-03 | 61.90 (5.80-660.64) |
 High | 41 |  |  |  |  |